Literature DB >> 20508806

A Case of Mania in a Patient with Systemic Lupus Erythematosus: Can Its Inflammatory Pathogenesis be Applied to Primary Mood Disorders?

David R Spiegel1, Lindsay Holtz, Kokil Chopra.   

Abstract

Systemic lupus erythematosus is a chronic inflammatory condition caused by an autoimmune disease. Systemic lupus erythematosus has been described as inducing neuropsychiatric symptoms, including mania and psychosis, in approximately 14 to 80 percent of systemic lupus erythematosus patients. We present and discuss the differential diagnoses in a patient with mania and systemic lupus erythematosus being treated with immunosuppresants and also with a history of glucose-6-phosphate dehydrogenase deficiency. Finally, we review the potential pathogenesis of mania due to an inflammatory-mediated etiology and how this may be used to partly explain the pathogenesis of primary mood disorders.

Entities:  

Year:  2010        PMID: 20508806      PMCID: PMC2877619     

Source DB:  PubMed          Journal:  Psychiatry (Edgmont)        ISSN: 1550-5952


  30 in total

Review 1.  [Neuropsychiatric lupus erythematosus].

Authors:  M Vadacca; F Buzzulini; A Rigon; G Coppolino; A Palma Modoni; R Massa; A Afeltra
Journal:  Reumatismo       Date:  2006 Jul-Sep

2.  Acute adverse reactions to prednisone in relation to dosage.

Authors: 
Journal:  Clin Pharmacol Ther       Date:  1972 Sep-Oct       Impact factor: 6.875

3.  Identification of brain lesions in neuropsychiatric systemic lupus erythematosus by magnetic resonance scanning.

Authors:  W J McCune; A MacGuire; A Aisen; S Gebarski
Journal:  Arthritis Rheum       Date:  1988-02

4.  A rating scale for mania: reliability, validity and sensitivity.

Authors:  R C Young; J T Biggs; V E Ziegler; D A Meyer
Journal:  Br J Psychiatry       Date:  1978-11       Impact factor: 9.319

5.  The time course of acute psychiatric episodes in systemic lupus erythematosus.

Authors:  M M Ward; S Studenski
Journal:  J Rheumatol       Date:  1991-04       Impact factor: 4.666

6.  Neuroprotection: a therapeutic strategy to prevent deterioration associated with schizophrenia.

Authors:  Jeffrey A Lieberman; Diana O Perkins; L Fredrik Jarskog
Journal:  CNS Spectr       Date:  2007-03       Impact factor: 3.790

7.  Ribosomal P autoantibodies in systemic lupus erythematosus. Frequencies in different ethnic groups and clinical and immunogenetic associations.

Authors:  F C Arnett; J D Reveille; H M Moutsopoulos; L Georgescu; K B Elkon
Journal:  Arthritis Rheum       Date:  1996-11

8.  Factors predictive of corticosteroid psychosis in patients with systemic lupus erythematosus.

Authors:  Shuk Yi Chau; Chi Chiu Mok
Journal:  Neurology       Date:  2003-07-08       Impact factor: 9.910

9.  Celecoxib as an adjunct in the treatment of depressive or mixed episodes of bipolar disorder: a double-blind, randomized, placebo-controlled study.

Authors:  Fabiano G Nery; Emel S Monkul; John P Hatch; Manoela Fonseca; Giovana B Zunta-Soares; Benício N Frey; Charles L Bowden; Jair C Soares
Journal:  Hum Psychopharmacol       Date:  2008-03       Impact factor: 1.672

10.  Prevalence of mood and anxiety disorders in women with systemic lupus erythematosus.

Authors:  Elizabeth A Bachen; Margaret A Chesney; Lindsey A Criswell
Journal:  Arthritis Rheum       Date:  2009-06-15
View more
  1 in total

1.  Case Report: Psychopathological Syndromes in the Course of Lupus Erythematosus and the Co-occurrence of Lupus Erythematous With Mental Disorders.

Authors:  Ewa Stelmach; Jolanta Masiak
Journal:  Front Psychiatry       Date:  2021-06-24       Impact factor: 4.157

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.